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Development of new vaccines for low resources settings is driven not only by the unmet medical need but also 
by addressing issues related to vaccine access, availability, affordability, acceptability and sustainability by the 
multitude of stakeholders involved in the research, development, introduction and scale-up of vaccines for low- 
and middle income countries (LMICs). The first gap that needs to be traversed is the valley of death between 
discovery and deployment (http://dx.doi.org/10.1038/453840a). Product Development Partnerships are one 
mechanism that has been successfully used to accelerate development of vaccines for LMICs. Two case 
studies will be reviewed: the meningitis A vaccine, MenAfriVac® and the malaria vaccine, Mosquirix®. A second 
valley of death has been identified in the development of the malaria vaccine (http://dx.doi.org/10.1016/S0140-
6736(16)30394-4). To traverse this second valley death, a different way of thinking about vaccine development 
may be required. 
 
 
